Nuvectis Pharma reports Q3 results
Source: SeekingAlpha
2025-11-04 12:31:33 ET
More on Nuvectis Pharma
- Seeking Alpha’s Quant Rating on Nuvectis Pharma
- Historical earnings data for Nuvectis Pharma
- Financial information for Nuvectis Pharma
Read the full article on Seeking Alpha
For further details see:
Nuvectis Pharma reports Q3 results
Nuvectis Pharma Inc.
NASDAQ: NVCT
NVCT Trading
-6.16% G/L:
$9.21 Last:
23,708 Volume:
$9.54 Open:
NVCT Latest News
February 11, 2026 07:30:00 am
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
NVCT Stock Data
$223,874,191
14,667,089
29.18%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Fort Lee
